Entos pulls in $53m Series A

Entos, Inc, a creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, has secured $53 million in Series A financing.

Entos, Inc, a creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, has secured $53 million in Series A financing. Coatue and Catalio Capital Management led the round with participation from OrbiMed, Sequoia Capital, Nexus Ventures and Freeflow.

Source: Press Release